Challenges and advancements in the pharmacokinetic enhancement of therapeutic proteins
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges and advancements in the pharmacokinetic enhancement of therapeutic proteins
Authors
Keywords
-
Journal
PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2021-01-18
DOI
10.1080/10826068.2020.1839907
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New proline, alanine, serine repeat sequence for pharmacokinetic enhancement of anti-VEGF single domain antibody
- (2020) Farnaz Khodabakhsh et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Recent Advances in Half-life Extension Strategies for Therapeutic Peptides and Proteins
- (2019) Huanbo Tan et al. CURRENT PHARMACEUTICAL DESIGN
- Selection of an Anticalin® against the membrane form of Hsp70 via bacterial surface display and its theranostic application in tumour models
- (2018) Lars Friedrich et al. BIOLOGICAL CHEMISTRY
- Prospects of PASylation® for the design of protein and peptide therapeutics with extended half-life and enhanced action
- (2018) Michaela Gebauer et al. BIOORGANIC & MEDICINAL CHEMISTRY
- PASylation as a Powerful Technology for Improving the Pharmacokinetic Properties of Biopharmaceuticals
- (2018) Sajjad Ahmadpour et al. Current Drug Delivery
- PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice
- (2018) Yuchen Xia et al. ANTIVIRAL RESEARCH
- Distribution of FcRn Across Species and Tissues
- (2017) Sari Latvala et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Molecular Design, Expression and Evaluation of PASylated Human Recombinant Erythropoietin with Enhanced Functional Properties
- (2017) Mohammad Hossein Hedayati et al. PROTEIN JOURNAL
- Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties
- (2017) Farnaz Khodabakhsh et al. Artificial Cells Nanomedicine and Biotechnology
- PASylated Coversin, a C5-Specific Complement Inhibitor with Extended Pharmacokinetics, Shows Enhanced Anti-Hemolytic Activity in Vitro
- (2016) Nadine Kuhn et al. BIOCONJUGATE CHEMISTRY
- Extension of in vivo half-life of biologically active molecules by XTEN protein polymers
- (2016) Vladimir N. Podust et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
- (2016) Peng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- OUP accepted manuscript
- (2016) PROTEIN ENGINEERING DESIGN & SELECTION
- Protein–polymer conjugation—moving beyond PEGylation
- (2015) Yizhi Qi et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Rational design of hyper-glycosylated interferon beta analogs: A computational strategy for glycoengineering
- (2015) Mojtaba Samoudi et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Head to Head Comparison of the Formulation and Stability of Concentrated Solutions of HESylated versus PEGylated Anakinra
- (2015) Robert Liebner et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- PASylation of Murine Leptin Leads to Extended Plasma Half-Life and Enhanced in Vivo Efficacy
- (2015) Volker Morath et al. MOLECULAR PHARMACEUTICS
- Anti-PEG immunity: emergence, characteristics, and unaddressed questions
- (2015) Qi Yang et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- GSK2374697, a Novel Albumin-Binding Domain Antibody (AlbudAb), Extends Systemic Exposure of Exendin-4: First Study in Humans—PK/PD and Safety
- (2014) R L O’Connor-Semmes et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
- (2014) Andreas Baumann et al. DRUG DISCOVERY TODAY
- Protein HESylation for half-life extension: Synthesis, characterization and pharmacokinetics of HESylated anakinra
- (2014) Robert Liebner et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Enhancedin VivoEfficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis
- (2014) Daniel Harari et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action
- (2014) Odile E. Levy et al. PLoS One
- Development and characterization of small bispecific albumin-binding domains with high affinity for ErbB3
- (2013) Johan Nilvebrant et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Glycosylation: impact, control and improvement during therapeutic protein production
- (2013) Ana Rita Costa et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
- (2013) M. Schlapschy et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Fc-fusion proteins: new developments and future perspectives
- (2012) Daniel M. Czajkowsky et al. EMBO Molecular Medicine
- Bacteriophages and their Implications on Future Biotechnology: A Review
- (2012) Irshad UL Haq et al. Virology Journal
- Strategies for extended serum half-life of protein therapeutics
- (2011) Roland E Kontermann CURRENT OPINION IN BIOTECHNOLOGY
- Design, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietin
- (2011) Dariush Norouzian et al. International Journal of Nanomedicine
- Recombinant elastin-mimetic biomaterials: Emerging applications in medicine
- (2010) Wookhyun Kim et al. ADVANCED DRUG DELIVERY REVIEWS
- Glycosylation of Therapeutic Proteins
- (2010) Ricardo J. Solá et al. BIODRUGS
- Stability of Protein Pharmaceuticals: An Update
- (2010) Mark Cornell Manning et al. PHARMACEUTICAL RESEARCH
- Gcg-XTEN: An Improved Glucagon Capable of Preventing Hypoglycemia without Increasing Baseline Blood Glucose
- (2010) Nathan C. Geething et al. PLoS One
- Size and Shape of Protein Molecules at the Nanometer Level Determined by Sedimentation, Gel Filtration, and Electron Microscopy
- (2009) Harold P. Erickson BIOLOGICAL PROCEDURES ONLINE
- Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects
- (2009) M. A. Bush et al. DIABETES OBESITY & METABOLISM
- Engineering a pharmacologically superior form of granulocyte-colony-stimulating factor by fusion with gelatin-like-protein polymer
- (2009) Yan-Shan Huang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
- (2009) Volker Schellenberger et al. NATURE BIOTECHNOLOGY
- Modulation of Antibody Pharmacokinetics by Chemical Polysialylation
- (2008) Antony Constantinou et al. BIOCONJUGATE CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now